Prostate cancer that changed type and spread to the liver and brain
Original title: Neuroendocrine transformation of prostate adenocarcinoma with liver and brain metastases: case report and literature review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is one patient's story and a look back at past reports, not a new treatment.
The short version
Doctors describe one patient whose prostate cancer changed into a faster growing kind and spread to the liver and brain.
What was studied. This is a report on one patient whose prostate cancer changed into a different type, called neuroendocrine. A sample taken from the liver confirmed the change. The authors also looked back at reports of seven similar cases.
What they found. The liver sample showed the cancer had turned into the neuroendocrine type. A lab test showed a growth marker of 95%, which means the cancer cells were dividing very fast. In the cases the authors reviewed, chemotherapy with platinum drugs was the main treatment, and patients did not live long.
What this means, and what it doesn't
What it could mean: This kind of change can happen even when PSA blood levels stay low. If cancer spreads quickly to organs like the liver or brain, doctors may want to take a sample from one of those new spots. That sample can show what the cancer has turned into. It can help doctors pick a treatment that fits.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is one patient's story plus a look back at a few past reports. Reports like this cannot prove that any treatment works. They are meant to remind doctors what to look for. There is nothing here for a patient to ask for or start today.
Source: PubMed, July 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.